Allergan Targets Hi-Tech Over IP For Glaucoma Generic
Allergan Inc. lodged a patent infringement suit in Texas federal court on Friday seeking to stop Hi-Tech Pharmacal Co. Inc. from launching a generic version of Allergan's glaucoma medication Lumigan....To view the full article, register now.
Already a subscriber? Click here to view full article